secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K
Filed at:   2024-08-09T23:59:59+00:00
Accession:  0001493152-24-030962
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonim Q2 revenue $11.5M, net loss $6.6M; expects H2 sequential growth
---------------------------------------------------------------------

- Net revenues of $11.5M, down from $16.8M in Q1 2024.
- GAAP net loss of $6.6M included a $3.2M impairment charge; adjusted EBITDA was -$2.0M.
- Ended quarter with $9.6M cash; raised $3.85M in an above-market equity transaction.
- Began product launches with tier-one carriers; expects sequential revenue growth in Q3 and Q4.
- Secured new product awards, including a 5G variant of the XP3plus flip phone with a US tier-one carrier.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000149315224030962/0001493152-24-030962-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000149315224030962/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-030962

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer